0.355 USD
+0.01 (+1.43%)
ChartMill assigns a Buy % Consensus number of 43% to TSBX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 1.02. This target is 187.32% above the current price.
- TSBX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about TSBX.
- In the previous month the buy percentage consensus was at a similar level.
- TSBX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-14 | B of A Securities | Downgrade | Buy -> Neutral |
| 2024-08-19 | B of A Securities | Maintains | Buy -> Buy |
| 2024-08-19 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-15 | B of A Securities | Initiate | Buy |
| 2023-08-15 | Piper Sandler | Initiate | Overweight |
TURNSTONE BIOLOGICS CORP / TSBX FAQ
What is the average price target for TURNSTONE BIOLOGICS CORP (TSBX) stock?
6 analysts have analysed TSBX and the average price target is 1.02 USD. This implies a price increase of 187.32% is expected in the next year compared to the current price of 0.355.
What is the consensus rating for TSBX stock?
The consensus rating for TURNSTONE BIOLOGICS CORP (TSBX) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.